Diagnostic and prognostic values of the QRS-T angle in patients with suspected acute decompensated heart failure. by Sweda, Romy et al.
Diagnostic and prognostic values of the QRS-T angle in
patients with suspected acute decompensated heart
failure
Romy Sweda1,2, Zaid Sabti3, Ivo Strebel3, Nikola Kozhuharov3, Desiree Wussler3, Samyut Shrestha3,
Dayana Flores3, Patrick Badertscher3, Pedro Lopez-Ayala3, Tobias Zimmermann3, Eleni Michou3,
Danielle M. Gualandro3, Andreas Häberlin1,2, Hildegard Tanner1, Dagmar I. Keller4, Albina Nowak5,
Otmar Pfister3, Tobias Breidthardt3, Christian Mueller3 and Tobias Reichlin1,3*
1Department of Cardiology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland; 2sitem Center for Translational Medicine and Biomedical
Entrepreneurship, University of Bern, Bern, Switzerland; 3Department of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, Basel,
Switzerland; 4Emergency Department, University Hospital Zurich, Zurich, Switzerland; 5Department of Endocrinology and Clinical Nutrition, University Hospital Zurich, Zurich,
Switzerland
Abstract
Aims The aim of this study was to investigate the diagnostic and prognostic utility of the QRS-T angle, an electrocardiogram
(ECG) marker quantifying depolarization–repolarization heterogeneity, in patients with suspected acute decompensated heart
failure (ADHF).
Methods and results We prospectively enrolled unselected patients presenting to the emergency department with symp-
toms suggestive of ADHF. The QRS-T angle was automatically derived from a standard 12-lead ECG recorded at presentation.
The primary diagnostic endpoint was a final adjudicated diagnosis of ADHF. The primary prognostic endpoint was all-cause
mortality during 2 years of follow-up. Among the 1915 patients enrolled, those with higher QRS-T angles were older, were
more commonly male, and had a higher rate of co-morbidities such as arterial hypertension, coronary artery disease, or
chronic kidney disease. ADHF was the final adjudicated diagnosis in 1140 (60%) patients. The QRS-T angle in patients with
ADHF was significantly larger than in patients with non-cardiac causes of dyspnoea {median 110° [inter-quartile range (IQR)
46–156°] vs. median 33° [IQR 15–57°], P < 0.001}. The diagnostic accuracy of the QRS-T angle as quantified by the area under
the receiver operating characteristic curve (AUC) was 0.75 [95% confidence interval (CI) 0.73–0.77, P < 0.001], which was in-
ferior to N-terminal pro-B-type natriuretic peptide (AUC 0.93, 95% CI 0.92–0.94, P < 0.001), but similar to that of
high-sensitivity troponin T (AUC 0.78, 95% CI 0.76–0.80, P = 0.09). The AUC of the QRS-T angle for discrimination between
ADHF and non-cardiac dyspnoea remained similarly high in subgroups of patients known to be diagnostically challenging, in-
cluding patients older than 75 years [0.71 (95% CI 0.67–0.74)], renal failure [0.79 (95% CI 0.71–0.87)], and atrial fibrillation at
presentation [0.68 (95% CI 0.60–0.76)]. Mortality rates according to QRS-T angle tertiles were 4%, 6%, and 10% after 30 days
(P < 0.001) and 24%, 31%, and 43% after 2 years (P < 0.001). After adjustment for clinical, laboratory, and ECG parameters,
the QRS-T angle remained an independent predictor for 2 year mortality with a 4% increase in mortality for every 20° increase
in QRS-T angle (P = 0.02).
Conclusions The QRS-T angle is a readily available and inexpensive marker that can assist in the discrimination between
ADHF and non-cardiac causes of acute dyspnoea and may aid in the risk stratification of these patients.
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Introduction
Acute decompensated heart failure (ADHF) is the most com-
mon reason for hospitalizations in the elderly and is a major
cause of morbidity and mortality in the western society.1
The majority of patients initially present to the emergency
department (ED) with the chief complaint of acute dyspnoea.
Given the broad differential diagnosis of this common symp-
tom—~7% of all non-traumatic ED admissions present with
respiratory distress—the identification of patients with ADHF
remains challenging.2
Besides history, physical examination, and blood tests, the
12-lead electrocardiogram (ECG) plays a key role in the
workup of patients with cardiorespiratory symptoms and is
usually obtained within minutes in the ED. Its value in acute
heart failure has, however, been limited predominantly to
the identification of potentially precipitating causes of ADHF
such as arrhythmias or myocardial infarction. Few studies
evaluated its utility beyond this scope and, among others,
identified prolongation of QRS and QTc duration to be associ-
ated with an increased risk for adverse events.3
A readily available ECG parameter that has recently gained
attention is the QRS-T angle. It is the angle between the axis
of the QRS complex and the axis of the T-wave and
represents a measure of cardiac depolarization–
repolarization heterogeneity. It has recently been shown to
improve the diagnostic accuracy in patients with suspected
non-ST-elevation myocardial infarction, and large QRS-T an-
gles have been associated with increased risk for ventricular
arrhythmias, hospitalizations, and mortality in various
populations.4–14
The utility of the QRS-T angle in patients with suspected
ADHF has not yet been assessed. The aim of this prospective
multicentre study was therefore to evaluate the diagnostic
and prognostic values of the QRS-T angle in patients present-
ing to the ED with symptoms suggestive of ADHF.
Methods
Study design and population
Unselected patients presenting to the Emergency Depart-
ments of the University Hospital of Basel or the University
Hospital of Zürich, Switzerland, with the leading symptom of
acute dyspnoea were prospectively enrolled between May
2001 and December 2015. Exclusion criteria were age below
18 years, an obvious traumatic cause of dyspnoea, cardio-
genic shock, and terminal kidney failure requiring dialysis.
The study was approved by the local ethics committees and
conducted according to the principles of the Declaration of
Helsinki. Written informed consent was obtained from all
patients.
Routine clinical assessment
In all patients, routine clinical assessment including demo-
graphical factors, medical history, physical examination,
12-lead ECG, continuous ECG monitoring, pulse oximetry,
standard blood tests, and chest radiography were performed.
Standard blood tests included high-sensitivity troponin T
(hs-TnT; Roche Diagnostics, Rotkreuz, Switzerland) and the
N-terminal pro-B-type natriuretic peptide (NT-proBNP; Roche
Diagnostics, Rotkreuz, Switzerland). Additional diagnostic
tests and therapeutic actions were left to the discretion of
the attending physician.
Adjudication of final diagnoses
The final diagnosis was adjudicated by a single internal med-
icine specialist up to 2002 and by two independent cardiolo-
gists thereafter in the core laboratories of the University
Hospitals Basel and Zürich after review of all available medical
records, including the baseline evaluation, results of subse-
quent laboratory and radiologic tests, ECGs, echocardiogra-
phies, response to therapy, and autopsy data if available,
from the time of ED presentation up to 90 days of follow-
up. In case of disagreement, a third cardiologist was
consulted, and consensus was found upon joined review of
available material. The diagnosis of ADHF was based on the
applicable guidelines of the European Society of Cardiology
for each period.15–18
Digital electrocardiogram recording, automated
calculation of the QRS-T angle, and automated
analysis of the QRS-T confounder type
Ten-second 12-lead ECGs were acquired as part of the rou-
tine clinical assessment in the ED using an AT-110 ECG device
(Schiller AG, Baar, Switzerland) or a Page Writer TC30 ECG de-
vice (Philips Healthcare, Andover, MA, USA). The digital ECG
raw data were recorded using a sampling rate of 500 Hz, a
resolution of 5 μV/bit, and a diagnostic signal bandwidth of
0.05 to 150 Hz (fulfilling the requirements by current interna-
tional ECG device standards).
The ETM V01.12.09.00 ECG analysis program (Schiller AG,
Baar, Switzerland) was used to automatically measure ECG
features, including amplitudes, depolarization and repolariza-
tion timings, and frontal plane QRS and T-wave axis (summa-
tion vector of frontal plane QRS, respectively, T-wave). To
minimize random noise and to improve the signal to noise ra-
tio, median beats were used for all quantitative measures as
described by Kligfield et al.19 To construct the median heart-
beat, a high-pass filter was applied to the ECG signal to re-
move baseline wandering. A QRS detector determined the
position of all heartbeats in the 10 s 12-lead ECGs. Beats were
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then classified by cross-correlation of the QRS complexes. The
QRS class with the most QRS complexes and the shortest QRS
duration was defined as the predominant normal heartbeat.
Those predominant normal heartbeats were then temporally
aligned by maximization of the cross-correlation of the QRS
complexes. From the aligned heartbeats, which are time se-
ries, a robust median was calculated for each time point
(sample) in the time series. The QRS-T angle was subse-
quently calculated as the absolute difference between the
QRS and T-wave axis. If the difference exceeded 180°, the
value was subtracted from 360° (Figure S1). Automated anal-
ysis of the ECG confounder types [intermediate: isolated right
bundle branch block (RBBB) and left ventricular hypertrophy;
remarkable: left bundle branch block, non-specific bundle
branch block, left anterior fascicular block (LAFB), and
RBBB + LAFB] was classified based on automated diagnostic
statement codes (ETM V01.12.09.00, Schiller AG, Baar,
Switzerland), QRS duration, and QRS axis as previously re-
ported by Strauss et al.20
Follow-up
Patients were contacted 1 and 2 years after hospital dis-
charge by phone or in written form by trained researchers.
In case of missing information, the national registry on mor-
tality, the hospital’s diagnosis registry, and the family physi-
cian’s records were assessed.
Outcomes and statistical analysis
Data are presented as median [inter-quartile range (IQR)] in
case of continuous variables and as numbers and percentages
in case of categorical variables. Comparison between groups
was performed using Pearson’s χ2 test, Mann–Whitney U
test, and Kruskal–Wallis test as appropriate. The primary di-
agnostic endpoint was an adjudicated final diagnosis of ADHF.
Pre-specified subgroup analyses for the diagnostic endpoint
were planned in patients with advanced age (>75 years),
atrial fibrillation (AF) at presentation, and renal failure
[estimated glomerular filtration rate (eGFR) < 30 mL/min/
1.73 m2]. Diagnostic accuracy was assessed by receiver oper-
ating characteristic (ROC) analysis with calculation of the area
under the ROC curve (AUC) and comparison of ROC AUCs
using the non-parametric method as recommended by
DeLong et al.21 Additionally, univariable and multivariable bi-
nary logistic regression models were computed to quantify
the association between selected baseline variables and the
diagnosis of ADHF as odds ratios (ORs) with 95% confidence
intervals (CIs). Variables were selected based on clinical im-
portance and tested for their association with the diagnosis
of ADHF in univariable analyses first. Parameters with a
P-value < 0.1 in univariate tests were entered into the multi-
variable model.
The primary prognostic endpoint was all-cause mortality
during 2 years of follow-up. The secondary prognostic end-
point was all-cause re-hospitalizations during 2 years of
follow-up. To evaluate time to event outcomes, we con-
structed Kaplan–Meier curves and used the log-rank test to
assess statistical significance. Univariable and multivariable
Cox proportional hazard analyses with calculation of hazard
ratios (HRs) with 95% CI were performed to quantify 2 year
mortality risk. As for logistic regression, we selected variables
by clinical reasoning and entered those with a P-value < 0.1
in univariable analysis into the multivariable model. For all
tests, a two-tailed P-value < 0.05 was considered to be statis-
tically significant. All analyses were performed using SPSS
Statistics version 25 (IBM, Chicago, Illinois, USA) and STATA
Statistical Software version 15.1 (StataCorp, College Station,
Texas, USA).
Results
Baseline characteristics
A total of 3116 unselected patients presenting to the ED with
the chief complaint of acute dyspnoea were enrolled be-
tween 2001 and 2015. After exclusion of patients without dig-
ital ECG records (n = 1158), with unclear final diagnoses
(n = 13) or with an adjudicated final diagnosis of
ST-elevation myocardial infarction or ventricular arrhythmia
(where no further diagnostics are required, n = 30), 1915 pa-
tients were available for analysis (Figure S2).
Baseline characteristics are presented in Table 1. ADHF
was the adjudicated final diagnosis in 60% of patients
(n = 1140). Non-cardiac causes of dyspnoea were responsi-
ble for the remaining 40% (n = 775) and included asthma
or chronic obstructive pulmonary disease (COPD) exacerba-
tions, bacterial or viral infections, pulmonary embolisms,
and other causes.
Levels of the QRS-T angle and QRS-T confounders
The median QRS-T angle in the overall population was 66°
(IQR 25–139°). Levels of the QRS-T angle were associated
with several baseline characteristics, as shown in Table 2.
Patients with higher QRS-T angles were older, were more
commonly male, and had a higher rate of co-morbidities such
as arterial hypertension, coronary artery disease, or chronic
kidney disease (CKD).
Presence and type of ECG confounders of cardiac depolar-
ization and repolarization resulted in significant changes in
the QRS-T angle. The ECG was free of confounders in 59%
of patients. In those, the median QRS-T angle was 39°
QRS-T angle in patients with suspected ADHF 1819
ESC Heart Failure 2020; 7: 1817–1829
DOI: 10.1002/ehf2.12746
(IQR 17–88°). It increased to 99° (IQR 41–149°) in patients
with intermediate ECG confounders (22% of patients overall)
and to 154° (IQR 108–170°) in those with remarkable ECG
confounders (19% of patients overall).
Diagnostic value of the QRS-T angle for the
discrimination between acute decompensated
heart failure and non-cardiac causes of dyspnoea
The QRS-T angle was significantly greater in patients with
ADHF compared with patients with non-cardiac causes of
dyspnoea [110° (IQR 46–156°) vs. 33° (IQR 15–57°),
P < 0.001, Figure 1A]. The diagnostic accuracy of the QRS-T
angle at presentation for discrimination between ADHF or
non-cardiac causes of dyspnoea as quantified by the AUC in
the overall cohort was 0.75 (95% CI 0.73–0.77, P < 0.001).
Choosing a cut-off value of 63° (based on Youden’s index),
70% of patients were correctly classified (sensitivity 69%,
specificity 73%, positive predictive value 79%, and negative
predictive value 61%; Table S1).
QRS-T angles were significantly higher in patients with
ADHF as compared with patients with non-cardiac causes of
dyspnoea irrespective of the presence and type of QRS-T
Table 1 Baseline characteristics
Variable
All patients
(n = 1915)
Acute decompensated heart failure
(n = 1140)
Non-cardiac dyspnoea
(n = 775) P-valuea
Age (years), median [IQR] 76 [64–83] 79 [70–85] 69 [56–78] <0.001
Male sex, n (%) 1071 (56) 646 (43) 425 (45) 0.43
BMI (kg/m2), median [IQR] 26 [23–30] 26 [23–30] 26 [22–30] 0.03
Current smoking, n (%) 396 (21) 196 (18) 200 (26) <0.001
Co-morbidities, n (%)
Art. hypertension 1340 (71) 893 (80) 447 (58) <0.001
Dyslipidaemia 841 (45) 578 (51) 263 (34) <0.001
Diabetes mellitus 454 (24) 323 (29) 131 (17) <0.001
CAD 708 (37) 556 (50) 152 (20) <0.001
Prior MI 391 (21) 314 (29) 77 (10) <0.001
PM, ICD, or CRT 147 (8) 140 (12) 7 (1) <0.001
Atrial fibrillation 547 (30) 472 (43) 75 (10) <0.001
COPD 610 (32) 284 (25) 326 (42) <0.001
CKD 606 (32) 502 (45) 103 (13) <0.001
Dyspnoea, n (%) <0.001
NYHA II 197 (10) 74 (6.5) 123 (16)
NYHA III 832 (43) 522 (46) 310 (40)
NYHA IV 805 (42) 496 (44) 309 (40)
Vital signs, median [IQR]
sBP (mmHg) 138 [122–156] 137 [20–156] 139 [125–156] 0.06
dBP (mmHg) 80 [68–91] 80 [68–93] 80 [69–90] 0.72
Heart rate (b.p.m.) 86 [72–101] 87 [71–105] 85 [73–99] 0.08
ECG findings, n (%) or median
[IQR]
Rhythm
Sinus 1436 (75) 712 (62) 724 (93) <0.001
Atrial fibrillation 479 (25) 428 (38) 51 (7) <0.001
Ventricular pacing 72 (4) 65 (6) 7 (1) <0.001
QRS duration (ms) 96 [86–118] 104 [90–132] 92 [84–100] <0.001
QTc time (ms) 454 [430–481] 468 [444–494] 439 [420–458] <0.001
QRS-T angle (°) 66 [25–139] 110 [46–156] 33 [15–67] <0.001
QRS-T confounders <0.001
None 1134 (59) 530 (47) 604 (78) <0.001
Intermediate 416 (22) 298 (26) 118 (15) <0.001
Remarkable 365 (19) 312 (27) 53 (6.8) <0.001
Laboratory tests, median [IQR]
Haemoglobin (g/L) 132 [117–145] 127 [113–141] 139 [136–150] <0.001
CRP (mg/L) 12 [3.7–38] 11 [4.1–31] 13 [3.0–58] 0.07
eGFR (mL/min/m2) 65 [42–86] 53 [35–74] 83 [62–99] <0.001
NT-proBNP (pg/mL)b 2032 [354–6453] 5083 [2237–9921] 252 [83–750] <0.001
hs-TnT (ng/mL)c 0.03 [0.01–0.05] 0.04 [0.02–0.07] 0.01 [0.01–0.03] <0.001
Abbreviations: Art, arterial; BMI, body mass index; CAD, coronary artery disease; CKD, chronic kidney disease; COPD, chronic obstructive
pulmonary disease; CRP, C-reactive protein; CRT, cardiac resynchronization therapy; dBP, diastolic blood pressure; eGFR, estimated glo-
merular filtration rate; hs-TnT, high-sensitivity troponin T; ICD, implantable cardioverter-defibrillator; MI, myocardial infarction; NT-
proBNP, N-terminal pro-B-type natriuretic peptide; PM, pacemaker; sBP, systolic blood pressure.
aFor comparison between acute decompensated heart failure and non-cardiac dyspnoea. Between-group comparisons were performed
using Pearson’s χ2 test in case of nominal and Mann–Whitney U test in case of ordinal or continuous variables.
bAvailable for 1848 patients.
cAvailable for 1791 patients.
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confounders (Figure 1B, all P < 0.001). Accordingly, the AUC
was not different for patients with no ECG confounders
(AUC 0.69, 95% CI 0.65–72), intermediate ECG confounders
(AUC 0.76, 95% CI 0.71–0.81), and remarkable ECG con-
founders (AUC 0.65, 95% CI 0.58–0.72).
The AUC of the QRS-T angle for discrimination between
ADHF and non-cardiac dyspnoea remained similarly high in
subgroups of patients known to be diagnostically challenging,
including patients older than 75 years [0.71 (95% CI 0.67–
0.74)], with renal failure [0.79 (95% CI 0.71–0.87)], and with
AF at presentation [0.68 (95% CI 0.60–0.76)]. For comparison,
the diagnostic accuracy of hs-TnT decreased from an AUC of
0.78 (95% CI 0.76–0.80) in the overall population and 0.68
(95% CI 0.65–0.72) in patients > 75 years, to 0.60 (95% CI
0.50–0.70) in patients with renal failure, and to 0.52 (95%
CI 0.43–0.61) in patients presenting with AF. The AUCs of
the QRS-T angle and hs-TnT were statistically not different
in the overall population and in patients > 75 years, while
in patients with renal failure and AF, the QRS-T angle was su-
perior to hs-TnT (P < 0.001 and P = 0.002). Compared with
Table 2 Patient characteristics stratified on QRS-T angle
Variable
QRS-T angle < 35°
(n = 641)
QRS-T angle 35–114°
(n = 635)
QRS-T angle > 114°
(n = 639) P-value
Age (years), median [IQR] 72 [59–82] 76 [64–83] 78 [69–84] <0.001
Male sex, n (%) 321 (50) 360 (57) 390 (61) <0.001
BMI (kg/m2), median [IQR] 26 [22–30] 26 [23–30] 26 [23–29] 0.72
Current smoking, n (%) 142 (23) 129 (21) 124 (20) 0.46
Co-morbidities, n (%)
Art. hypertension 413 (65) 442 (70) 485 (78) <0.001
Dyslipidaemia 248 (39) 258 (42) 335 (55) <0.001
Diabetes mellitus 120 (19) 153 (24) 181 (29) <0.001
CAD 171 (27) 207 (33) 330 (53) <0.001
Prior MI 83 (13) 118 (19) 190 (31) <0.001
PM, ICD, or CRT 21 (3) 37 (6) 89 (14) <0.001
Atrial fibrillation 113 (18) 183 (30) 251 (41) <0.001
COPD 232 (36) 213 (34) 165 (26) 0.003
CKD 140 (22) 175 (28) 291 (47) <0.001
Dyspnoea, n (%) <0.001
NYHA II 84 (13) 77 (12) 36 (5.6)
NYHA III 288 (45) 255 (40) 289 (45)
NYHA IV 244 (38) 271 (43) 290 (45)
Vital signs, median [IQR]
sBP (mmHg) 138 [124–157] 140 [125–158] 133 [117–152] <0.001
dBP (mmHg) 80 [68–91] 81 [68–93] 79 [67–91] 0.29
Heart rate (b.p.m.) 83 [70–97] 87.3 [74–103] 88.6 [73–106] <0.001
ECG findings, n (%) or median [IQR]
Rhythm
Sinus 548 (86) 478 (75) 410 (64) <0.001
Atrial fibrillation 93 (15) 157 (25) 229 (36) <0.001
Ventricular pacing 8 (1) 13 (2) 51 (8) <0.001
QRS duration (ms) 90 [84–98] 96.0 [86–110] 116.0 [96–144] <0.001
QTc time (ms) 442 [423–465] 453.0 [431–473] 473.0 [446–501] <0.001
QRS-T confounders, n (%)
None 535 (84) 403 (64) 196 (31) <0.001
Intermediate 88 (14) 156 (25) 172 (27) <0.001
Remarkable 18 (2.8) 76 (12) 271 (42) <0.001
Laboratory tests, median [IQR]
Haemoglobin (g/L) 133 [119–146] 133 [120–146] 130 [115–142] 0.001
CRP (mg/L) 11 [3–47] 14 [4–42] 11 [4–30] 0.03
eGFR (mL/min/m2) 75 [52–93] 65 [44–88] 52 [36–75] <0.001
NT-proBNP (pg/mL)a 508 [118–2536] 1831 [312–5240] 5556 [2066–11 663] <0.001
hs-TnT (ng/mL)b 0.02 [0.01, 0.04] 0.02 [0.01–0.05] 0.04 [0.02–0.07] <0.001
Discharge diagnosis, n (%) <0.001
ADHF 232 (36) 365 (58) 543 (85)
Non-cardiac cause 409 (64) 270 (43) 96 (15)
Abbreviations: ADHF, acute decompensated heart failure; Art, arterial; BMI, body mass index; CAD, coronary artery disease; COPD, chronic
obstructive pulmonary disease; CKD, chronic kidney disease; CRP, C-reactive protein; CRT, cardiac resynchronization therapy; dBP, diastolic
blood pressure; eGFR, estimated glomerular filtration rate; hs-TnT, high-sensitivity troponin T; ICD, implantable cardioverter-defibrillator;
MI, myocardial infarction; NT-proBNP, N-terminal pro-B-type natriuretic peptide; PM, pacemaker; sBP, systolic blood pressure.
Between-group comparisons were performed using Pearson’s χ2 test in case of nominal and Kruskal–Wallis test in case of ordinal or con-
tinuous variables.
aAvailable for 1848 patients.
bAvailable for 1791 patients.
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those of NT-proBNP (the biomarker assisting in gold-standard
adjudication in this study), the AUCs of both the QRS-T angle
and hs-TnT were lower in the overall population as well as in
all subgroups (Table S1). Cut-offs with respective sensitivities,
specificities, and positive and negative predictive values are
summarized in Table S2.
Without adjustment for other factors, the odds for ADHF
increased by 42% (OR 1.42, 95% CI 1.37–1.48, P < 0.001)
for every 20° increase of the QRS-T angle (Table S3). In a
multivariable model including patient age, body mass
index (BMI), medical history (arterial hypertension,
dyslipidaemia, coronary artery disease, AF, and COPD),
eGFR, NT-proBNP, hs-TnT, and QRS and QTc duration, the
QRS-T angle remained predictive for ADHF with an OR of
1.17 (95% CI 1.10–1.24) per 20° increase (P < 0.001;
Table S3).
Figure 1 QRS-T angle in patients with acute decompensated heart failure versus other causes of acute dyspnoea. QRS-T angle in patients with ADHF
(displayed in red) and non-cardiac causes of acute dyspnoea (displayed in blue) in the overall population (A), and stratified according to the presence of
no, intermediate (RBBB, LVH), and remarkable (LAFB, RBBB+LAFB, LBBB, and NBBB) ECG confounders (B). Mann–Whitney U test used for comparison.
Abbreviations: ADHF, acute decompensated heart failure; RBBB, right bundle branch block; LVH, left ventricular hypertrophy; LAFB, left anterior fas-
cicular block; LBBB, left bundle branch block; NBBB, non-specific bundle branch block.
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Prognostic value of the QRS-T angle
A total of 793 patients (42%) died during a median follow-up
time of 28 months (IQR 27–39). Those who died had
significantly higher QRS-T angles than had survivors [96°
(IQR 35–153°) vs. 51° (IQR 20–121°), P < 0.001]. Survival ac-
cording to QRS-T angle tertiles was 96%, 94%, and 90% after
30 days (P < 0.001) and 76%, 69%, and 57% after 2 years
Figure 2 Prognostic value of the QRS-T angle with respect to all-cause mortality. Kaplan–Meier survival estimates according to QRS-T angle tertiles in
the overall population (A), in patients with acute decompensated heart failure (B), and in patients with non-cardiac cause of acute dyspnoea (C).
QRS-T angle in patients with suspected ADHF 1823
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(P < 0.001, Figure 2A). The QRS-T angle was associated with
survival both in patients with ADHF (Figure 2B) and in pa-
tients with non-cardiac causes of dyspnoea (Figure 2C).
Similarly, the QRS-T angle predicted freedom from
re-hospitalizations during 2 years of follow-up in the overall
cohort (Figure 3A), as well as in the subgroups of patients
Figure 3 Prognostic value of the QRS-T angle with regard to all-cause re-hospitalizations. Cumulative re-hospitalization risk according to QRS-T angle
tertiles in the overall population (A), in patients with acute decompensated heart failure (B), and in patients with non-cardiac cause of acute dyspnoea
(C).
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with ADHF (Figure 3B) and non-cardiac causes of dyspnoea
(Figure 3C).
In univariable Cox proportional hazard analysis, the QRS-T
angle predicted mortality after 2 years in the whole popula-
tion with an HR of 1.12 (95% CI 1.09–1.14, P < 0.001) for ev-
ery 20° increment (Table 3). It remained predictive of 2 year
mortality even after adjustment for age, sex, BMI,
co-morbidities (arterial hypertension, dyslipidaemia, coronary
artery disease, AF, and COPD), systolic blood pressure, eGFR,
NT-proBNP, hs-TnT, and QRS and QTc duration (HR 1.04, 95%
CI 1.01–1.07, P = 0.02; Table 3). Similar results were observed
also for re-hospitalizations (HR 1.42, 95% CI 1.37–1.48,
P < 0.001 in univariable analysis, HR 1.17, 95% CI 1.10–
1.24, P < 0.001 in multivariable analysis adjusting for the fac-
tors mentioned above, per 20° increase of the QRS-T angle),
as shown in Table S3.
Discussion
This large multicentre observational cohort study assessed
the diagnostic and prognostic values of the QRS-T angle, a
simple and readily available, observer-independent ECG
marker quantifying depolarization–repolarization heteroge-
neity, in patients admitted to the ED with the chief complaint
of acute dyspnoea suggestive of ADHF. We observed five ma-
jor findings:
First, the QRS-T angle was significantly higher—nearly
three times as high—in patients with ADHF compared with
non-cardiac causes of acute dyspnoea. After adjustment
for several clinical, laboratory, and ECG variables, the odds
for ADHF increased by 17% for every 20° increase in the
QRS-T angle. Second, the diagnostic accuracy of the QRS-T
angle to detect patients with ADHF was similar to that of
hs-TnT and, in contrast to the latter, remained high in sub-
groups of patients known to be diagnostically challenging,
such as those with renal failure and AF. Third, patients with
higher QRS-T angles had a higher risk for re-hospitalizations
and mortality. During 2 years of follow-up, nearly 50% of pa-
tients in the highest QRS-T angle tertile died, which was al-
most twice as many as those in the lowest tertile. Fourth,
even after adjustment for multiple baseline characteristics,
including but not limited to age, co-morbidities, and
importantly NT-proBNP, the QRS-T angle remained indepen-
dently predictive of 2 year mortality with a risk increase of
4% for every 20°. Fifth, the QRS-T angle predicted
re-hospitalizations and mortality both in patients with ADHF
as well as those with non-cardiac causes of dyspnoea inde-
pendently, highlighting its prognostic value irrespective from
the underlying condition.
These findings have several clinical implications. Despite
advances in diagnostic abilities, rapid and reliable identifica-
tion of patients with acute heart failure in the emergency set-
ting remains challenging. Imaging modalities provide ample
information, yet their limited availability and dependence
on operator skills restrict their applicability to centres with
Table 3 Univariable and multivariable predictors for long-term mortality in patients presenting to the emergency department with acute
dyspnoea
Univariable Multivariable
HR LCI UCI P-value HR LCI UCI P-value
Age (per year) 1.05 1.04 1.06 <0.001 1.04 1.03 1.05 <0.001
Male sex 0.87 0.76 1.01 0.08 0.76 0.65 0.90 0.001
BMI 0.95 0.94 0.96 <0.001 0.96 0.94 0.97 <0.001
Medical history
Art. hypertension 1.63 1.37 1.94 <0.001 0.97 0.79 1.20 0.80
Dyslipidaemia 1.24 1.07 1.43 0.004 0.93 0.77 1.11 0.42
CAD 1.60 1.39 1.85 <0.001 1.05 0.87 1.25 0.63
Atrial fibrillation 1.60 1.38 1.86 <0.001 0.99 0.84 1.18 0.98
COPD 1.21 1.04 1.40 0.01 1.37 1.16 1.61 <0.001
Diabetes mellitus 1.17 0.99 1.37 0.05 1.35 1.12 1.63 0.002
Vital signs
Heart rate (b.p.m.) 1.00 1.00 1.00 0.74 — — — —
sBP (per 10 mmHg) 0.92 0.90 0.95 <0.001 0.94 0.91 0.97 <0.001
Laboratory tests
eGFR > 60 mL/min/m2 0.40 0.35 0.47 <0.001 0.64 0.54 0.77 <0.001
NT-proBNP (per 100 pg/mL) 1.001 1.001 1.001 <0.001 1.000 1.000 1.001 <0.001
hs-TnT (per ng/mL) 1.61 1.28 2.03 <0.001 1.18 0.87 1.56 0.29
ECG parameters
QRS-T angle (per 20°) 1.12 1.09 1.14 <0.001 1.04 1.01 1.07 0.02
QRS duration (per 10 ms) 1.07 1.05 1.10 <0.001 0.99 0.99 1.00 0.64
QTc duration (per 10 ms) 1.05 1.03 1.07 <0.001 1.00 0.99 1.10 0.18
Abbreviations: Art, arterial; BMI, body mass index; CAD, coronary artery disease; CI, confidence interval; eGFR, estimated glomerular fil-
tration rate; HR, hazard ratio; hs-TnT, high-sensitivity troponin T; LCI, lower confidence interval; NT-proBNP, N-terminal pro-B-type natri-
uretic peptide; sBP, systolic blood pressure; UCI, upper confidence interval.
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on-site expertise. Blood tests are invaluable in the assess-
ment of suspected ADHF. However, the time it takes until re-
sults are obtained may delay diagnosis and treatment
initiation, which has been associated with prolonged hospital-
ization durations and increased mortality.22,23 A 12-lead ECG
is routinely obtained in any patient with potentially cardiac
mediated symptoms and has the advantage of general avail-
ability and immediate interpretability. Its role in acute heart
failure, however, has been primarily restricted to the identifi-
cation of potentially precipitant causes for ADHF.15,24 So far,
no single ECG parameter has been found to predict the prob-
ability of ADHF even though it is recognized that patients with
heart failure often have abnormal ECGs.24 Accordingly, the
QRS-T angle reported in this study is the first readily available
and easily interpretable ECG parameter that may aid in the
diagnosis of patients with suspected ADHF. To put it in con-
text, we compared its diagnostic value for a diagnosis of
ADHF with that of hs-TnT, which has increasingly gained at-
tention owing to its potential diagnostic and prognostic
impact,25–27 as well as with that of NT-proBNP, which was
used as the biochemical gold standard for the adjudicated fi-
nal diagnosis of ADHF. Not surprisingly, both the QRS-T angle
and hs-TnT had a lower diagnostic performance than
NT-proBNP. On the other hand, the diagnostic accuracy of
the QRS-T angle in the overall population was similar to that
of hs-TnT and, in contrast to troponin, which lost its informa-
tive value in patients with renal failure and AF, remained high
in these populations. Patients with co-morbidities are known
to be diagnostic challenging; nevertheless, they present a
substantial proportion of patients presenting to the ED with
respiratory distress—in our study, ~30% of patients had a his-
tory of AF or CKD, which is comparable with other cohorts in
this setting. Including the easily available QRS-T angle—to-
gether with any other available information—into the full pic-
ture may aid in the diagnostic process and enhance fast yet
accurate triage and resource allocation in order to ensure op-
timal management of patients.
Triage and resource allocation are central in EDs, which
are faced with ever-rising patient volumes with increasingly
complex disease manifestations.28 Proper triage relies on
adequate risk stratification and can be improved by incor-
poration of prognostic markers.29 A number of previous in-
vestigations examined the prognostic value of the QRS-T
angle in various populations, including patients with arterial
hypertension, diabetes, CKD, myocarditis, implanted cardiac
devices, chronic heart failure, and suspected and confirmed
myocardial ischaemia, as well as in the general
population.4–14 Across the spectrum, greater QRS-T angles
were associated with increased risk of adverse events, re-
hospitalizations, and mortality. These findings were corrob-
orated in our study, which was the first to evaluate the
prognostic value of the QRS-T angle in patients with symp-
toms suggestive of ADHF. Also, in our population, larger
QRS-T angles were predictive of re-hospitalizations and
mortality, even after adjustment for multiple clinically rele-
vant variables. Other ECG parameters that have been previ-
ously implied in a greater risk of adverse events, including
death, in patients with ADHF are the QRS and QTc
duration.3,30 Also, in our cohort, both QRS and QTc dura-
tion were associated with mortality during follow-up in
univariable analysis but lost their significance upon adjust-
ment for other baseline variables. Thus, among the ECG pa-
rameters readily available to the caretaker, the QRS-T angle
may provide the greatest prognostic information, as has
been suggested also in earlier reports.13 A reason for this
observation may lie in the fact that the QRS-T angle is
likewise affected by abnormal depolarization as well as re-
polarization, which makes it more robust and less suscepti-
ble to noise than parameters measuring either of these
factors alone. Moreover, the QRS-T angle is a measure of
electrical heterogeneity, which can occur at various stages
in cardiac disease and is known to predispose for poten-
tially lethal arrhythmias.
The findings of this study have to be interpreted in con-
sideration of following limitations: First, patients with termi-
nal renal failure requiring dialysis were excluded, wherefore
the findings do not apply to this population. Second, the ef-
fect estimates of our multivariable analyses may be consid-
ered small. However, as the QRS-T angle is by no means
meant to replace other parameters but shall rather be seen
in conjuncture with them, also small contributions may sum
up to a common whole and should therefore not be
neglected—especially when they are free of additional effort
and cost. Third, we calculated only the frontal QRS-T angle,
while some authors have suggested that the spatial QRS-T
angle may have higher diagnostic and prognostic accuracy.31
Fourth, we did not discriminate between newly diagnosed
acute heart failure and decompensation of previously known
chronic heart failure. Further investigations are needed to
examine possible differences between these populations.
Fifth, no detailed information was available on pacing modes
in patients with cardiac devices. We were able to report the
amount of patients with ventricular pacing but lack the data
on atrial pacing. However, from a pathophysiological point
of view, we do not think that atrial pacing should have
had a relevant impact on the QRS-T angle. And finally, the
analyses are based on QRS-T angles derived at a single point
in time (i.e. at ED admission). While previous studies sug-
gested that the QRS-T angle was relatively stable over time,
it is possible that it may be acutely affected in the setting of
decompensated heart failure.4,9 In the context of our cur-
rent study, only admission ECGs were recorded. This pre-
cludes us from analysing the QRS-T angle at discharge of
the index hospitalization, and accordingly of the temporal
QRS-T angle variability. The topic however should be ad-
dressed in future studies and could even find a potential
value of the QRS-T angle as an indicator of treatment re-
sponse in patients with ADHF.
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Conclusions
The QRS-T angle, a quickly obtainable and readily interpret-
able ECG parameter, may aid in the diagnosis of patients with
suspected ADHF and independently predicts mortality during
2 years of follow-up. Being usually available within minutes
after patients contact, it can assist in the early management
and decision process until results of more advanced tests be-
come available.
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